Delcath Systems, Inc. is an oncology company, which engages in the treatment of primary and metastatic liver cancers. Its products include CHEMOSAT and HEPZATO. The company was founded in August 1988 and is headquartered in Queensbury, NY.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of DCTH is 9.85 USD — it has decreased by −2.83% in the past 24 hours. Watch Delcath Systems, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Delcath Systems, Inc. stocks are traded under the ticker DCTH.
DCTH stock has fallen by −0.62% compared to the previous week, the month change is a −15.67% fall, over the last year Delcath Systems, Inc. has showed a 228.33% increase.
We've gathered analysts' opinions on Delcath Systems, Inc. future price: according to them, DCTH price has a max estimate of 25.00 USD and a min estimate of 18.00 USD. Watch DCTH chart and read a more detailed Delcath Systems, Inc. stock forecast: see what analysts think of Delcath Systems, Inc. and suggest that you do with its stocks.
DCTH reached its all-time high on Apr 29, 2010 with the price of 515,872,000,000.00 USD, and its all-time low was 2.25 USD and was reached on Nov 14, 2023. View more price dynamics on DCTH chart. See other stocks reaching their highest and lowest prices.
DCTH stock is 4.07% volatile and has beta coefficient of 1.85. Track Delcath Systems, Inc. stock price on the chart and check out the list of the most volatile stocks — is Delcath Systems, Inc. there?
Today Delcath Systems, Inc. has the market capitalization of 307.91 M, it has increased by 4.33% over the last week.
Delcath Systems, Inc. is going to release the next earnings report on Apr 1, 2025. Keep track of upcoming events with our Earnings Calendar.
DCTH earnings for the last quarter are 0.06 USD per share, whereas the estimation was −0.20 USD resulting in a 130.00% surprise. The estimated earnings for the next quarter are −0.04 USD per share. See more details about Delcath Systems, Inc. earnings.
Delcath Systems, Inc. revenue for the last quarter amounts to 11.20 M USD, despite the estimated figure of 10.46 M USD. In the next quarter, revenue is expected to reach 12.43 M USD.
DCTH net income for the last quarter is 1.86 M USD, while the quarter before that showed −13.74 M USD of net income which accounts for 113.57% change. Track more Delcath Systems, Inc. financial stats to get the full picture.
No, DCTH doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 21, 2024, the company has 76.00 employees. See our rating of the largest employees — is Delcath Systems, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Delcath Systems, Inc. EBITDA is −26.46 M USD, and current EBITDA margin is −1.84 K%. See more stats in Delcath Systems, Inc. financial statements.
Like other stocks, DCTH shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Delcath Systems, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Delcath Systems, Inc. technincal analysis shows the neutral today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Delcath Systems, Inc. stock shows the sell signal. See more of Delcath Systems, Inc. technicals for a more comprehensive analysis. If you're still not sure, try looking for inspiration in our curated watchlists.